DermTech, Inc. (DMTK) CEO John Dobak on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/14/21
DermTech Management to Present at the UBS Global Healthcare Virtual ConferenceBusiness Wire • 05/11/21
DermTech Presents Mini-Symposia at 2021 Society of Investigational Dermatology Virtual SummitBusiness Wire • 05/10/21
DermTech, Inc. (DMTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks Investment Research • 05/06/21
DermTech Pledges up to $1 Million to Raise Awareness and Support Accessibility of Skin ExamsBusiness Wire • 05/03/21
DermTech, Inc. (DMTK) Moves 11.1% Higher: Will This Strength Last?Zacks Investment Research • 04/28/21
DermTech to Collaborate on Longitudinal Study on Hidradenitis Suppurativa (HS)Business Wire • 04/27/21
DermTech Introduces PLAplus with Improved Sensitivity for Early Detection of MelanomaBusiness Wire • 04/22/21
OptumInsight Study Describes Cost Savings of DermTech's Pigmented Lesion Assay in the Management of MelanomaBusiness Wire • 04/15/21
Should Investors Be Worried About DermTech's Decline From Its 52-Week Highs?The Motley Fool • 03/25/21
DermTech's (DMTK) CEO John Dobak on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/05/21